Josep Dalmau

About me

Featured publications

• Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders

  Authors:

  Guasp, Mar; Rosa-Justicia, Mireia; Munoz-Lopetegi, Amaia; Martinez-Hernandez, Eugenia; Armangue, Thais;

  (...)

  Llufriu, Sara; Sanchez-Valle, Raquel; Santamaria, Joan; Castro-Fornielest, Josefina; Dalmau, Josep.

  See complete list of authors

  Reference: Lancet Neurology 2022.

• Human CASPR2 Antibodies Reversibly Alter Memory and the CASPR2 Protein Complex

  Authors:

  Joubert, Bastien; Petit-Pedrol, Mar; Planaguma, Jesus; Mannara, Francesco; Radosevic, Marija;

  (...)

  Gasull, Xavier; Loza-Alvarez, Pablo; Sabater, Lidia; Rosenfeld, Myrna R; Dalmau, Josep.

  See complete list of authors

  Reference: Annals Of Neurology 2022.

• Neurofilament light chain levels in anti-NMDAR encephalitis and primary psychiatric psychosis

  Authors:

  Guasp, Mar; Martin-Aguilar, Lorena; Sabater, Lidia; Bioque, Miquel; Armangue, Thais;

  (...)

  Castro-Fornieles, Josefina; Parellada, Eduard; Graus, Francesc; Querol, Luis; Dalmau, Josep.

  See complete list of authors

  Reference: Neurology 2022.

• Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis

  Authors:

  Guasp, Mar; Gine-Serven, Eloi; Maudes, Estibaliz; Rosa-Justicia, Mireia; Martinez-Hernandez, Eugenia;

  (...)

  Saiz, Albert; Graus, Francesc; Castro-Fornieles, Josefina; Parellada, Eduard; Dalmau, Josep.

  See complete list of authors

  Reference: Neurology 2021.

• Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis

  Authors:

  Mannara, Francesco; Radosevic, Marija; Planaguma, Jesus; Soto, David; Aguilar, Esther;

  (...)

  Quirk, Michael; Dai, Jing; Gasul, Xavier; Lewis, Mike; Dalmau, Josep.

  See complete list of authors

  Reference: Brain 2020.

• LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory

  Authors:

  Petit-Pedrol, M; Planagumà, J; Mannara, F; Radosevic, M; Sabater, L;

  (...)

  Dalmau, J; Sell, J; Haselmann, H; Ceanga, M; Geis, C.

  See complete list of authors

  Reference: Brain 2018.

• Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis

  Authors:

  Armangue, Thais; Spatola, Marianna; Vlagea, Alexandru; Mattozzi, Simone; Carceles-Cordon, Marc;

  (...)

  Alsina, Laia; Saiz, Albert; Rosenfeld, Myrna R; Graus, Francesc; Dalmau, Josep.

  See complete list of authors

  Reference: Lancet Neurology 2018.

• Investigations in GABAA receptor antibody-associated encephalitis.

  Authors:

  Spatola, Marianna; Petit-Pedrol, Mar; Simabukuro, Mateus Mistieri; Armangue, Thas; Castro, Fernanda J;

  (...)

  Felipe, Ana; Oblitas, Ruben L Caparo; Rosenfeld, Myrna R; Graus, Francesc; Dalmau, Josep.

  See complete list of authors

  Reference: Neurology 2017.

• Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice

  Authors:

  Planagumà, J; Leypoldt, F; Mannara, F; Aguilar, E; Petit-Pedrol, M;

  (...)

  Martín-García, E; Maldonado, R; Titulaer, MJ; Jain, A; Balice-Gordon, R.

  See complete list of authors

  Reference: Brain 2015.

• Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

  Authors:

  Titulaer, Maarten J; McCracken, Lindsey; Gabilondo, Inigo; Armangue, Thais; Glaser, Carol;

  (...)

  Torrents, Abiguei; Saiz, Albert; Rosenfeld, Myrna R; Balice-Gordon, Rita; Dalmau, Josep.

  See complete list of authors

  Reference: Lancet Neurology 2013.

Featured Projects

• Antibody-mediated NMDA receptor encephalitis: symptoms, biomarkers, and mechanisms of the prolonged recovery stage

  Principal investigator: Josep Dalmau Obrador

  Funder: Fundación La Caixa

  Code: HR22-00221

  Duration: 01/12/2022 - 30/11/2025

• Investigations in anti-NMDAR encephalitis: New diagnostic test, the role of inflammation in an animal model, and allosteric modulation of NMDAR as a therapeutic strategy

  Principal investigator: Josep Dalmau Obrador

  Funder: Instituto de Salud Carlos III

  Code: PI20/00197

  Duration: 01/01/2021 - 31/12/2023

• A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-NMDA Receptor Encephalitis and Assess Markers of Disease

  Principal investigator: Josep Dalmau Obrador

  Funder: NeuroNext National Institutes of Health USA

  Duration: 18/01/2023 - 31/03/2027

• Social and Psychological long-term impact of NMDA receptor encephalitis

  Principal investigator: Josep Dalmau Obrador

  Funder: Instituto de Salud Carlos III

  Code: AC21-2/00053

  Duration: 01/01/2022 - 31/12/2024